Toxic liver disease (K71)

    • ICD-10 Index

      • Diseases of the digestive system (K00–K93)

        • Diseases of liver (K70-K77)

            • Toxic liver disease (K71)
            • K71 - Toxic liver disease NON-BILLABLE CODE
            • K71.0 - Toxic liver disease with cholestasis BILLABLE CODE
            • K71.1 - Toxic liver disease with hepatic necrosis NON-BILLABLE CODE
            • K71.10 - Toxic liver disease with hepatic necrosis, without coma BILLABLE CODE
            • K71.11 - Toxic liver disease with hepatic necrosis, with coma BILLABLE CODE
            • K71.2 - Toxic liver disease with acute hepatitis BILLABLE CODE
            • K71.3 - Toxic liver disease with chronic persistent hepatitis BILLABLE CODE
            • K71.4 - Toxic liver disease with chronic lobular hepatitis BILLABLE CODE
            • K71.5 - Toxic liver disease with chronic active hepatitis NON-BILLABLE CODE
            • K71.50 - Toxic liver disease w chronic active hepatitis w/o ascites BILLABLE CODE
            • K71.51 - Toxic liver disease w chronic active hepatitis with ascites BILLABLE CODE
            • K71.6 - Toxic liver disease with hepatitis, not elsewhere classified BILLABLE CODE
            • K71.7 - Toxic liver disease with fibrosis and cirrhosis of liver BILLABLE CODE
            • K71.8 - Toxic liver disease with other disorders of liver BILLABLE CODE
            • K71.9 - Toxic liver disease, unspecified BILLABLE CODE

Clinical Information for Toxic liver disease (K71)

Alagille Syndrome - A multisystem disorder that is characterized by aplasia of intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC), and malformations in the cardiovascular system, the eyes, the vertebral column, and the facies. Major clinical features include JAUNDICE, and congenital heart disease with peripheral PULMONARY STENOSIS. Alagille syndrome may result from heterogeneous gene mutations, including mutations in JAG1 on CHROMOSOME 20 (Type 1) and NOTCH2 on CHROMOSOME 1 (Type 2).

Cholestasis - Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS).

Cholestasis, Extrahepatic - Impairment of bile flow in the large BILE DUCTS by mechanical obstruction or stricture due to benign or malignant processes.

Cholestasis, Intrahepatic - Impairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC).

Cryptogenic Organizing Pneumonia - An interstitial lung disease of unknown etiology, occurring between 21-80 years of age. It is characterized by a dramatic onset of a "pneumonia-like" illness with cough, fever, malaise, fatigue, and weight loss. Pathological features include prominent interstitial inflammation without collagen fibrosis, diffuse fibroblastic foci, and no microscopic honeycomb change. There is excessive proliferation of granulation tissue within small airways and alveolar ducts.

Bile Ducts - The channels that collect and transport the bile secretion from the BILE CANALICULI, the smallest branch of the BILIARY TRACT in the LIVER, through the bile ductules, the bile ducts out the liver, and to the GALLBLADDER for storage.

Instructional Notations

Includes Includes
This note appears immediately under a three character code title to further define, or give examples of, the content of the category.

  • drug-induced idiosyncratic (unpredictable) liver disease
  • drug-induced toxic (predictable) liver disease

Code First Code First
Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10-CM has a coding convention that requires the underlying condition be sequenced first followed by the manifestation. Wherever such a combination exists, there is a "use additional code" note at the etiology code, and a "code first" note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.

  • poisoning due to drug or toxin, if applicable T36 T65

Use Additional Code Use Additional Code
The “use additional code” indicates that a secondary code could be used to further specify the patient’s condition. This note is not mandatory and is only used if enough information is available to assign an additional code.

  • code for adverse effect, if applicable, to identify drug T36 T50

Type 2 Excludes Type 2 Excludes
A type 2 excludes note represents "Not included here". An excludes2 note indicates that the condition excluded is not part of the condition represented by the code, but a patient may have both conditions at the same time. When an Excludes2 note appears under a code, it is acceptable to use both the code and the excluded code together, when appropriate.

  • alcoholic liver disease K70
  • Budd-Chiari syndrome I82.0